相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome:: An open-label, pilot study in 10 pediatric patients
Ewa Piotrowska et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2008)
Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease
Melanie D. White et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Improvement in behaviour after substrate deprivation therapy with rhodamine B in a mouse model of NIPSIIIA
Ainslie L. K. Roberts et al.
MOLECULAR GENETICS AND METABOLISM (2007)
A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer et al.
MOLECULAR GENETICS AND METABOLISM (2007)
A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years
Monica Sifuentes et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA
Ainslie L. K. Roberts et al.
PEDIATRIC RESEARCH (2006)
Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo
Xugang Xia et al.
NEUROBIOLOGY OF DISEASE (2006)
Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses
Ewa Piotrowska et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2006)
Enzyme replacement therapy for mucopolysaccharidosis VI: A Phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
Paul Harmatz et al.
JOURNAL OF PEDIATRICS (2006)
Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production
R Koldej et al.
JOURNAL OF GENE MEDICINE (2005)
Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII
C Vogler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease
C Moyses
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2003)
Gaucher disease and the clinical experience with substrate reduction therapy
A Zimran et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2003)
RNA interference targeting Fas protects mice from fulminant hepatitis
EW Song et al.
NATURE MEDICINE (2003)
The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: A position statement
TM Cox et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2003)
Heparin and heparan sulfate biosynthesis
K Sugahara et al.
IUBMB LIFE (2002)
Gene silencing using micro-RNA designed hairpins
MT McManus et al.
RNA (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode α1,4-N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/heparin biosynthesis
BT Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Synthesis of 4-deoxy-4-fluoro analogues of 2-acetamido-2-deoxy-D-glucose and 2-acetamido-2-deoxy-D-galactose and their effects on cellular glycosaminoglycan biosynthesis
A Berkin et al.
CARBOHYDRATE RESEARCH (2000)
分享论文
